JPJakub Pietrucha

Jakub Pietrucha

*This is an algorithmically generated author record based on publicly available information.

Jakub Pietrucha has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sustaining the Quality of Sports Participation and Life Standards in Aging Men: A Systematic Review of Physical Activity and Urological Health Management

    by Dawid Studziński, Wiktoria Szkatuła, Karolina Osińska, Anna Kołcz, Michał Kulczak, Konrad Turczynowski, Kamil Turczynowski, Alicja Trzepizur, Jakub Pietrucha, Izabela Ochońska

    This systematic review formulates an organizational service framework integrating clinical urological data with sports management practices to mitigate disease-induced dropout among aging male athletes. Following PRISMA guidelines, a systematic search of PubMed (2021–2026) yielded 22 primary open-access articles evaluating physical activity, sedentary behaviors, and male urological or renal outcomes. High-volume cohort data confirms a robust inverse relationship between regular physical activity and the severity of lower urinary tract symptoms and erectile dysfunction, though extreme training volumes display a non-linear risk threshold. In clinical rehabilitation phases, supervised technological exercises paired with behavioral compliance models significantly accelerate post-surgical continence recovery. Longitudinally, overactive bladder symptoms serve as independent predictors of upper-limb grip strength decline and physical frailty. Sports enterprises can optimize service quality and member retention by moving from generic configurations toward age-appropriate, urologically sustainable exercise designs. Practical administrative interventions include expanding facility restroom accessibility to reduce public anxiety and embedding non-invasive urological screening metrics into routine physical assessments to preserve lifelong functional longevity.

  • Open Access

    The impact of resistance training and collagen supplementation on joint stability and prevention of recurrent ankle sprains in amateur athletes: A Literature review

    by Jakub Pietrucha, Wojciech Kuna, Kamil Igor Turczynowski, Konrad Olaf Turczynowski, Mateusz Józef Gołdyn, Zuzanna Łyko, Anna Rutkowska, Jakub Niski, Dawid Studziński

    Introduction: Ankle injuries are among the most common medical issues in the physically active population, accounting for nearly 15–30% of all sports-related injuries. The most frequent of these is the inversion sprain, which leads to damage of the lateral ligament complex, particularly the anterior talofibular ligament (ATFL). Although this injury is often downplayed in popular opinion, research indicates that improper treatment and a lack of rehabilitation lead to the development of chronic ankle instability (CAI) in nearly 40% of patients. Aim: The aim of this study is to review current literature regarding the role of sensorimotor training and collagen peptide supplementation in the process of strengthening ligamentous structures and improving the subjective perception of joint stability in athletes. Background: For the amateur athlete, recurrent sprains involve not only physical pain but, above all, a drastic decline in the Quality of Life (QoL), resulting from the necessity to interrupt training and increasing kinesiophobia—the fear of reinjury. Contemporary sports orthopedics is increasingly shifting away from a purely mechanical paradigm of injury treatment toward a holistic approach. The key pillars of this approach are resistance training focused on active stabilization and biochemical support through targeted collagen supplementation Review methods:A comprehensive analysis ofr esearch papers available on PubMed and GoogleScholar was conducted using keywords:

  • Open Access

    Do SGLT2 Inhibitors Affect Skeletal Muscle Mass and Strength? A Systematic Review of Body Composition and Functional Outcomes

    by Konrad Turczynowski, Jakub Lichoń, Zuzanna Łyko, Wojciech Kuna, Jakub Pietrucha, Mateusz Gołdyn, Jakub Niski, Anna Rutkowska, Dawid Studziński

    Background. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are widely used in the treatment of type 2 diabetes mellitus, chronic kidney disease, and heart failure. Although these agents promote weight loss and improve cardiometabolic outcomes, concerns have emerged regarding potential reductions in skeletal muscle mass and their impact on physical function. Aim. To review current evidence on the effects of SGLT2 inhibitors on skeletal muscle mass, muscle strength, and functional outcomes. Material and methods. A systematic narrative review of English-language studies published between 2020 and 2026 was conducted. Randomized controlled trials, observational studies, and meta-analyses evaluating body composition and functional performance outcomes during SGLT2 inhibitor therapy were included. Results. SGLT2 inhibitors consistently reduced body weight primarily through fat mass loss, while reductions in lean mass were generally small. Skeletal muscle mass and handgrip strength were largely preserved in middle-aged adults, whereas greater variability was observed in older individuals and patients with chronic kidney disease. Evidence suggests that physical activity and adequate nutrition may mitigate potential muscle loss. Conclusions. SGLT2 inhibitors promote favorable body recomposition with predominantly fat mass reduction and minimal effects on muscle function in most patients. Monitoring muscle health and supporting lifestyle interventions may be beneficial in vulnerable populations.

  • Open Access

    Impact of GLP-1 Receptor Agonists on Body Composition and Physical Performance in Patients with Obesity: A Comprehensive Review of Current Research

    by Konrad Turczynowski, Jakub Lichoń, Paweł Kuna, Wojciech Kuna, Jakub Pietrucha, Mateusz Gołdyn, Jakub Niski, Anna Rutkowska, Dawid Studziński

    Background.GLP-1 receptor agonists (GLP-1RAs) are central to obesity pharmacotherapy, producing substantial and sustained weight loss in randomized trials, with additional cardiometabolic benefits. Growing attention concerns their effects on body composition, particularly fat versus lean mass loss, and potential impacts on skeletal muscle function and physical performance. These outcomes are highly relevant to sports medicine and rehabilitation, where muscle preservation is crucial. Aim.To review evidence on the effects of GLP-1RAs on body composition and physical performance in adults with obesity, focusing on fat mass, lean mass and populations at risk of muscle-related adverse effects. Materials and methods.Narrative review of 30 PubMed-indexed studies (2015–2026), including RCTs, DXA substudies and reviews of liraglutide, semaglutide and tirzepatide in adults with overweight/obesity. Results.GLP-1RAs consistently reduced body weight and fat mass, with 15–40% of weight loss attributable to lean mass reduction. Semaglutide improved physical function and exercise tolerance in obesity-related functional impairment and HFpEF, while potential sarcopenic effects were reported in older adults and those with low baseline muscle mass. Reviews highlight heterogeneity of lean mass responses and the importance of lifestyle interventions. Conclusions.GLP-1RAs induce major fat loss but are associated with clinically relevant lean mass loss. Combining pharmacotherapy with exercise and nutrition is essential to optimize body composition and physical performance.

  • Open Access

    Application of Machine Learning Algorithms in Automatic Anesthetic Drug Delivery Systems: A literature review

    by Jakub Michał Lichoń, Paweł Jan Kuna, Wojciech Kuna, Jakub Mateusz Pietrucha, Kamil Igor Turczynowski, Mateusz Józef Gołdyn, Konrad Olaf Turczynowski

    The dynamic advancements in artificial intelligence are enabling the integration of machine learning into medical practice. A significant challenge in modern anesthesiology is the need for precise, continuous adjustment of anesthetic drug doses in response to the patient's rapidly changing physiological state. Traditional manual methods of drug delivery often result in excessive variability in the depth of anesthesia and hemodynamic stability. Utilizing machine learning algorithms represents a modern, promising approach designed to enhance the overall quality and safety of anesthetic care. Aim of the study: The objective of this study is to review the current state of knowledge concerning machine algorithms in automated anesthetic drug delivery systems and to compare these with conventional administration methods, evaluating the benefits and limitations of each approach. Materials and methods: A review of selected literature in the PubMed, Google Scholar database was conducted, using the following keywords: “anesthetic drugs”, “machine learning”, “closed-loop system” “artificial intelligence” Conclusions: The review demonstrates that Machine Learning-driven Closed-Loop Anesthesia Delivery Systems (CLADS) offer superior stability of anesthetic depth and hemodynamic control compared to manual administration. The implementation of AI allows for the personalization of therapy and a significant reduction in drug and gas wastage, supporting the "Green Anesthesia" initiative. Furthermore, automation contributes to better long-term outcomes, such as reduced incidence of postoperative delirium and cognitive dysfunction. However, despite high autonomy, the "human-in-the-loop" paradigm remains essential due to technical artifacts and unforeseen surgical events. Future research should focus on regulatory standardization and the integration of multi-loop systems managing hypnosis, analgesia, and neuromuscular blockade simultaneously.


  • Open Access

    Evaluation of the Efficacy and Safety of Thalamotomy and Pallidotomy Using Focused Ultrasound (FUS) in the Treatment of Essential Tremor and Parkinson’s Disease: A Literature Review

    by Paweł Jan Kuna, Mateusz Gołdyn, Konrad Turczynowski, Jakub Pietrucha, Jakub Lichoń, Wojciech Kuna, Alicja Chojniak, Wiktoria Haberko

    Introduction: Parkinson’s Disease (PD) and Essential Tremor (ET) are the two most prevalent movement disorders, with tremor being a core, often drug-refractory, motor feature. While traditional surgical treatments like Deep Brain Stimulation (DBS) and Radiofrequency (RF) ablation are effective, they are invasive and carry inherent risks such as hemorrhage and infection, necessitating craniotomy. This reality drives the need for less invasive therapeutic options for patients with advanced, medication-refractory symptoms and motor fluctuations. Aim: The aim of this systematic review is to assess the clinical efficacy and safety profile of Thalamotomy and Pallidotomy performed using Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) technology in the treatment of Essential Tremor and Parkinson’s Disease. Review methods: A comprehensive analysis of research papers available on PubMed and Google Scholar was conducted using keywords: Focused Ultrasound (FUS), Essential Tremor (ET), Parkinson's Disease (PD), Thalamotomy, Pallidotomy, MRgFUS. Conclusion: MRgFUS-guided thalamotomy (VIM) and pallidotomy (GPi) constitute a breakthrough, non-invasive alternative to traditional surgical ablations. The technology demonstrates high and durable efficacy, achieving a 47% reduction in ET tremor and a 39,1% reduction in PD motor symptoms (UPDRS III), comparable to invasive standards. Crucially, MRgFUS offers a favorable safety profile by eliminating the risk of surgical bleeding and infection while providing real-time lesion monitoring. However, a key limitation remains the requirement for an adequate Skull Density Ratio (SDR), excluding some clinically eligible patients. Further long-term, prospective studies are required to fully establish its role.

  • Open Access

    Modern pharmacological strategies in the treatment of Drug-Resistant Epilepsy: evaluation of efficacy and safety: a review

    by Wojciech Kuna, Jakub Niski, Jakub Mateusz Pietrucha, Anna Rutkowska, Jakub Michał Lichoń, Mateusz Józef Gołdyn, Paweł Jan Kuna, Kamil Igor Turczynowski, Alicja Katarzyna Chojniak, Konrad Olaf Turczynowski

    Drug-resistant epilepsy (DRE) is a neurological condition, defined as a failure to make the patient seizure free, after the use of two tolerated, appropriately chosen antiepileptic drugs (AED). Although there is an increasing number of available antiepileptic drugs, it is estimated that pharmacotherapy remains ineffective in approximately 30% of patients. Drug-resistant epilepsy is considered as one of the greatest challenges in modern neurology that affects millions of patients worldwide, who do not respond to standard treatments. Even though epilepsy is one of the most common neurological diseases, with a global total of 50 million people suffering from the condition, treatment of its resistant forms remains complicated and often ineffective. Chronic epileptic seizures can cause serious health problems, limiting patients' mobility, affecting quality of life and increasing the risk of emotional disorders such as depression and anxiety. In response to this challenge, the development of modern drugs for drug-resistant epilepsy has become a medical priority. In recent years, there has been growing interest in new medications such as Cenobamate, Fenfluramine and Cannabidiol, which have different mechanisms of action and promising results in reducing the seizure frequency. Before diagnosing DRE, it is essential to exclude the pseudo-resistance, which may result from different factors such as inadequate doses of medicine, choosing the incorrect medications, or patient-related errors (poor compliance).